FDA accepted Eisai and Biogen's BLA for Leqembi subcutaneous autoinjector for Alzheimer's disease treatment. If approved, Leqembi will be the only subcutaneous AD treatment for home use.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing
FDA To Review Under the Skin Weekly Autoinjector For Biogen/Eisai's Alzheimer's Drug Leqembi
